These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8106765)

  • 1. Opsonic antibodies to Staphylococcus epidermidis: in vitro and in vivo studies using human intravenous immune globulin.
    Fischer GW; Cieslak TJ; Wilson SR; Weisman LE; Hemming VG
    J Infect Dis; 1994 Feb; 169(2):324-9. PubMed ID: 8106765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of slime-producing S. epidermidis specific antibodies in human immunoglobulin preparations and blood sera by an enzyme immunoassay: correlation of antibody titers with opsonic activity and application to preterm neonates.
    Lamari F; Anastassiou ED; Stamokosta E; Photopoulos S; Xanthou M; Dimitracopoulos G; Karamanos NK
    J Pharm Biomed Anal; 2000 Aug; 23(2-3):363-74. PubMed ID: 10933528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intravenous immune globulin in newborn infants.
    Fischer GW
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):73-7. PubMed ID: 8033439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonic defense to Staphylococcus epidermidis in the premature neonate.
    Fleer A; Gerards LJ; Aerts P; Westerdaal NA; Senders RC; van Dijk H; Verhoef J
    J Infect Dis; 1985 Nov; 152(5):930-7. PubMed ID: 4045255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonic activity of commercially available standard intravenous immunoglobulin preparations.
    Weisman LE; Cruess DF; Fischer GW
    Pediatr Infect Dis J; 1994 Dec; 13(12):1122-5. PubMed ID: 7892082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fibrinogen binding protein of Staphylococcus epidermidis is a target for opsonic antibodies.
    Rennermalm A; Nilsson M; Flock JI
    Infect Immun; 2004 May; 72(5):3081-3. PubMed ID: 15102827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state.
    Cerca N; Jefferson KK; Oliveira R; Pier GB; Azeredo J
    Infect Immun; 2006 Aug; 74(8):4849-55. PubMed ID: 16861673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses and opsonic activity in sera of preterm neonates with coagulase-negative staphylococcal septicemia and the effect of the administration of fresh frozen plasma.
    Krediet TG; Beurskens FJ; van Dijk H; Gerards LJ; Fleer A
    Pediatr Res; 1998 May; 43(5):645-51. PubMed ID: 9585011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.
    Basma H; Norrby-Teglund A; McGeer A; Low DE; El-Ahmedy O; Dale JB; Schwartz B; Kotb M
    Infect Immun; 1998 May; 66(5):2279-83. PubMed ID: 9573118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directed immune globulin for the prevention or treatment of neonatal group B streptococcal infections: a review.
    Fischer GW; Weisman LE; Hemming VG
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S92-7. PubMed ID: 1728993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
    Givner LB
    Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in opsonic requirements of Staphylococcus epidermidis: relative importance of surface hydrophobicity, capsules and slime.
    van Bronswijk H; Verbrugh HA; Heezius HC; Renders NH; Fleer A; van der Meulen J; Oe PL; Verhoef J
    Immunology; 1989 May; 67(1):81-6. PubMed ID: 2737697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsonic activity of intravenous immunoglobulin preparations against Staphylococcus epidermidis.
    Clark LA; Easmon CS
    J Clin Pathol; 1986 Aug; 39(8):856-60. PubMed ID: 3745476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of Murine Models for Assessment of Antibody-Mediated Therapies or Vaccine Candidates against Staphylococcus epidermidis Bloodstream Infection.
    Cole LE; Zhang J; Kesselly A; Anosova NG; Lam H; Kleanthous H; Yethon JA
    Infect Immun; 2016 Apr; 84(4):1143-1149. PubMed ID: 26857577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid.
    Theilacker C; Kropec A; Hammer F; Sava I; Wobser D; Sakinc T; Codée JD; Hogendorf WF; van der Marel GA; Huebner J
    J Infect Dis; 2012 Apr; 205(7):1076-85. PubMed ID: 22362863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of conjugated PIA-rSesC and immunological evaluation against biofilm-forming Staphylococcus epidermidis.
    Mirzaei B; Mousavi SF; Babaei R; Bahonar S; Siadat SD; Shafiee Ardestani M; Shahrooei M; Van Eldere J
    J Med Microbiol; 2019 May; 68(5):791-802. PubMed ID: 30990402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates.
    Weisman LE; Anthony BF; Hemming VG; Fischer GW
    J Pediatr; 1993 Jun; 122(6):929-37. PubMed ID: 8501574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of epitope specificity in the human opsonic antibody response to the staphylococcal surface polysaccharide poly N-acetyl glucosamine.
    Kelly-Quintos C; Kropec A; Briggs S; Ordonez CL; Goldmann DA; Pier GB
    J Infect Dis; 2005 Dec; 192(11):2012-9. PubMed ID: 16267775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus epidermidis ΔSortase A strain elicits protective immunity against Staphylococcus aureus infection.
    Tan C; Wang J; Hu Y; Wang P; Zou L
    Antonie Van Leeuwenhoek; 2017 Jan; 110(1):133-143. PubMed ID: 27757703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified human immune serum globulin for intravenous administration: in vitro opsonic activity and in vivo protection against group B streptococcal disease in suckling rats.
    Fischer GW; Hunter KW; Wilson SR
    Acta Paediatr Scand; 1982 Jul; 71(4):639-44. PubMed ID: 6753478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.